These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 10406614)

  • 1. Ciprofloxacin-resistant Pseudomonas keratitis.
    Garg P; Sharma S; Rao GN
    Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
    Sharma V; Sharma S; Garg P; Rao GN
    Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
    Jang CH; Park SY
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.
    Kunimoto DY; Sharma S; Garg P; Rao GN
    Ophthalmology; 1999 Jan; 106(1):80-5. PubMed ID: 9917785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial susceptibility patterns for microbial isolates associated with infectious keratitis in horses: 63 cases (1986-1994).
    Moore CP; Collins BK; Fales WH
    J Am Vet Med Assoc; 1995 Oct; 207(7):928-33. PubMed ID: 7559027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of clinical characteristics and bacterial isolates in dogs with bacterial keratitis: 97 cases (1993-2003).
    Tolar EL; Hendrix DV; Rohrbach BW; Plummer CE; Brooks DE; Gelatt KN
    J Am Vet Med Assoc; 2006 Jan; 228(1):80-5. PubMed ID: 16426172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
    Kowalski RP; Pandya AN; Karenchak LM; Romanowski EG; Husted RC; Ritterband DC; Shah MK; Gordon YJ
    Ophthalmology; 2001 Oct; 108(10):1826-9. PubMed ID: 11581056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and causative organisms in microbial keratitis.
    Green M; Apel A; Stapleton F
    Cornea; 2008 Jan; 27(1):22-7. PubMed ID: 18245962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial keratitis after manual descemet stripping endothelial keratoplasty--a different pathophysiology?
    Sengupta J; Khetan A; Saha S; Ganguly A; Pal D
    Eye Contact Lens; 2010 Jan; 36(1):62-5. PubMed ID: 19935426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and outcome of nocardia keratitis.
    Sridhar MS; Sharma S; Garg P; Rao GN
    Cornea; 2001 Jul; 20(5):458-62. PubMed ID: 11413397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
    Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
    Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin monotherapy and bacterial keratitis.
    Katz HR
    Ophthalmology; 1999 Oct; 106(10):1853-4. PubMed ID: 10519570
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility of bacterial isolates from bacterial keratitis cases in a university hospital in Taiwan.
    Fong CF; Hu FR; Tseng CH; Wang IJ; Chen WL; Hou YC
    Am J Ophthalmol; 2007 Nov; 144(5):682-689. PubMed ID: 17764652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endophthalmitis caused by Pseudomonas aeruginosa.
    Eifrig CW; Scott IU; Flynn HW; Miller D
    Ophthalmology; 2003 Sep; 110(9):1714-7. PubMed ID: 13129867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
    Al-Jasser AM; Elkhizzi NA
    Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
    Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T
    Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.